Sign In to Follow Application
View All Documents & Correspondence

Antisense Guide Rna With Added Functional Region For Editing Target Rna

Abstract: Problem: Providing antisense guide RNA for editing target RNA by ADAR. Solution: Antisense guide RNA, for editing target RNA by ADAR, wherein: at least one functional region and an antisense region that is complementary to part of the target RNA and forms a double strand with the target RNA are included; and the at least one functional region is joined to the antisense region and substantially does not include an ADAR-recruiting base sequence. Representative drawing: None

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
06 July 2022
Publication Number
27/2022
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
patent@depenning.com
Parent Application

Applicants

ASTELLAS PHARMA INC.
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411

Inventors

1. YOSHIMI, Eiji
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
2. MORIYA, Yukari
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
3. MANDA, Mariko
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
4. GOTOH, Takayasu
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411
5. ARAI, Takatomo
c/o Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 1038411

Specification

Documents

Application Documents

# Name Date
1 202247038782-FORM 18 [20-11-2023(online)].pdf 2023-11-20
1 202247038782.pdf 2022-07-06
2 202247038782-STATEMENT OF UNDERTAKING (FORM 3) [06-07-2022(online)].pdf 2022-07-06
2 202247038782-FORM 3 [29-03-2023(online)].pdf 2023-03-29
3 202247038782-SEQUENCE LISTING(PDF) [06-07-2022(online)].pdf 2022-07-06
3 202247038782-Correspondence_GPA_27-12-2022.pdf 2022-12-27
4 202247038782-SEQUENCE LISTING [06-07-2022(online)].txt 2022-07-06
4 202247038782-FORM 3 [08-12-2022(online)].pdf 2022-12-08
5 202247038782-PRIORITY DOCUMENTS [06-07-2022(online)].pdf 2022-07-06
5 202247038782-Correspondence_Proof of Right (Form 1)_30-08-2022.pdf 2022-08-30
6 202247038782-FORM-26 [10-08-2022(online)].pdf 2022-08-10
6 202247038782-FORM 1 [06-07-2022(online)].pdf 2022-07-06
7 202247038782-Proof of Right [04-08-2022(online)].pdf 2022-08-04
7 202247038782-DECLARATION OF INVENTORSHIP (FORM 5) [06-07-2022(online)].pdf 2022-07-06
8 202247038782-COMPLETE SPECIFICATION [06-07-2022(online)].pdf 2022-07-06
9 202247038782-Proof of Right [04-08-2022(online)].pdf 2022-08-04
9 202247038782-DECLARATION OF INVENTORSHIP (FORM 5) [06-07-2022(online)].pdf 2022-07-06
10 202247038782-FORM 1 [06-07-2022(online)].pdf 2022-07-06
10 202247038782-FORM-26 [10-08-2022(online)].pdf 2022-08-10
11 202247038782-PRIORITY DOCUMENTS [06-07-2022(online)].pdf 2022-07-06
11 202247038782-Correspondence_Proof of Right (Form 1)_30-08-2022.pdf 2022-08-30
12 202247038782-SEQUENCE LISTING [06-07-2022(online)].txt 2022-07-06
12 202247038782-FORM 3 [08-12-2022(online)].pdf 2022-12-08
13 202247038782-SEQUENCE LISTING(PDF) [06-07-2022(online)].pdf 2022-07-06
13 202247038782-Correspondence_GPA_27-12-2022.pdf 2022-12-27
14 202247038782-STATEMENT OF UNDERTAKING (FORM 3) [06-07-2022(online)].pdf 2022-07-06
14 202247038782-FORM 3 [29-03-2023(online)].pdf 2023-03-29
15 202247038782.pdf 2022-07-06
15 202247038782-FORM 18 [20-11-2023(online)].pdf 2023-11-20